Abstract:
Ethiopia has successfully managed to lead a well-coordinated response plan including vaccination
of COVID-19 vaccines to stop the spread of COVID-19 and address the human and economic
impacts on the society. The Ethiopian Food and Drug Authority (FDA) has been working to
ensure the availability of quality assured COVID-19 vaccines through providing Emergency Use
Authorization (EUA) and monitoring of vaccine safety and conducting Adverse Events Following
Immunization (AEFI) surveillances. EFDA has been issuing EUA for COVID 19 vaccine
manufacturers as per the requirement of EFDA Guideline for EUA of COVID 19 vaccines.
